Journal
SMALL
Volume 16, Issue 48, Pages -Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/smll.202004492
Keywords
3D microfluidic chips; accurate cancer diagnosis; exosomal biomarkers; miRNAs; stage monitoring
Categories
Funding
- National Natural Science Foundation of China [21627806, 21635004, 21705018]
- National Key R&D Program of China [2017YFF0108606]
- Fundamental Research Funds for the Central Universities [2242017K3DN11, 2242020K40030]
Ask authors/readers for more resources
Exosomes are recognized as promising biomarkers for early cancer diagnosis and prognosis owing to a large amount of biological information they carried. But the key is that single type of exosomal biomarker analysis is not sufficient enough for accurate cancer diagnosis and stage monitoring due to the insufficient information and high false positive signal. To address the challenge, here simultaneous in situ detection of different types of exosomal biomarkers (surface proteins: CD81, ephrin type-A receptor 2, and carbohydrate antigen 19-9; miRNAs: miR-451a, miR-21, and miR-10b) is conducted with a 3D microfluidic chip, which works in conjunction with quantum dot (QD) labeling and vesicle fusion technology. After exosomes are efficiently captured by the microfluidic chip, the quantification of multiple exosomal proteins is achieved by using three kinds of QDs with the same excitation and different emission wavelengths, and virus-mimicking fusogenic vesicles encapsulating three exquisitely engineered molecular beacons are introduced for ultrasensitive detection of multiple exosomal miRNAs without requiring RNA extraction. Through comprehensive profiling different types of exosomal biomarkers, the false positive rate is substantially avoided and the accuracy of cancer diagnosis and stage monitoring is improved to approximate to 100%, which are critical to cancer effective treatment and favorable prognosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available